Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia

Table 1 Demographic and medication data of participants according to aripiprazole formulation prescribed (N = 122)

Data are presented as means ± standard deviations.
AOM, aripiprazole once-monthly; BMI, body mass index; PANSS, Positive and Negative Syndrome Scale; LAI, long-acting injectable.
Age, duration of illness, BMI, CPZeq, BPDeq, DZPeq, and PANSS total score were compared between the two groups using Student’s t-test.
Male/female, inpatient/outpatient, smoker/non-smoker proportions were compared using the chi-square test.
The proportions of men/women, inpatients/outpatients, and smokers/non-smokers were compared among the four groups using the chi-square test.
^a Daily dose of aripiprazole converted to an approximate chlorpromazine equivalent.
^b Daily dose of anticholinergic antiparkinsonian drugs converted to an approximate biperiden equivalent.
^c Daily dose of benzodiazepine converted to an approximate diazepam equivalent.

ISSN: 1471-244X